REG - RUA Life Sciences - Result of AGM

Rua Life SciencesAnnouncement

Yesterday 17:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260317:nRSQ0237Xa&default-theme=true

RNS Number : 0237X  RUA Life Sciences PLC  17 March 2026

17 March 2026

 

RUA Life Sciences plc

("RUA" the "Company" or the "Group")

 

Result of AGM

RUA Life Sciences plc (AIM:RUA), the holding company of a group of medical
device businesses focused on implantable textiles and the leading biostable
polymer (Elast-Eon™), announces that all resolutions put forward to its
Annual General Meeting held earlier today were duly passed, and the votes cast
were as follows:

 

 Res No.  Votes For  %       Votes Against  %      Votes Total  % V.C.  Votes Withheld
 01       6,996,885  98.88%  78,936         1.12%  7,075,821    11.40   0
 02       6,962,437  98.41%  112,576        1.59%  7,075,013    11.40   808
 03       6,995,836  98.88%  79,177         1.12%  7,075,013    11.40   808
 04       7,010,744  99.08%  65,077         0.92%  7,075,821    11.40   0
 05       7,010,744  99.08%  65,077         0.92%  7,075,821    11.40   0
 06       6,963,273  98.88%  78,936         1.12%  7,042,209    11.35   33,612
 07       6,963,273  98.41%  112,548        1.59%  7,075,821    11.40   0
 08       6,996,885  98.88%  78,936         1.12%  7,075,821    11.40   0
 09       6,963,273  98.41%  112,548        1.59%  7,075,821    11.40   0
 10       7,010,716  99.08%  65,105         0.92%  7,075,821    11.40   0
 11       6,907,147  97.62%  168,579        2.38%  7,075,726    11.40   95
 12       6,907,147  97.62%  168,579        2.38%  7,075,726    11.40   95
 13       6,907,360  97.62%  168,366        2.38%  7,075,726    11.40   95
 14       6,957,401  98.33%  118,365        1.67%  7,075,766    11.40   55

 

The full text of each of the resolutions is set out in the notice of Annual
General Meeting, copies of which are available on the Company's website
(www.rualifesciences.com (http://www.rualifesciences.com/) ).

 

For further information contact:

 RUA Life Sciences                                                     Tel: +44 (0)1294 317073
 Bill Brown, CEO
 Lachlan Smith, CFO

 Cavendish Capital Markets                                             Tel: +44 (0)20 7220 0500
 Limited
 (Nominated Adviser and Broker)
 Giles Balleny/Isaac Hooper (Corporate Finance)
 Harriet Ward (Broking)
 Nigel Birks (Healthcare Specialist Sales)
 Michael Johnson (Sales)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUBVNRNRUOAAR



            Copyright 2019 Regulatory News Service, all rights reserved